MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

Search

Aurinia Pharmaceuticals Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

8.16 0.74

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

8.13

Max

8.18

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-13M

1.4M

Pardavimai

-7.9M

60M

P/E

Sektoriaus vid.

191.5

57.333

Pelnas, tenkantis vienai akcijai

0.01

Pelno marža

2.387

Darbuotojai

130

EBITDA

-14M

7.2M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+19.19% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-05-01

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-94M

1.1B

Ankstesnė atidarymo kaina

7.42

Ankstesnė uždarymo kaina

8.16

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bullish Evidence

Aurinia Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-04-25 17:01; UTC

Uždarbis
Pagrindinės rinkos jėgos

Aon Shares Sink After 1Q Profit Falls, Sales Miss Estimates

2025-04-25 16:10; UTC

Uždarbis
Pagrindinės rinkos jėgos

Coursera Shares Rise After 1Q Beat, Better-Than-Expected Revenue View

2025-04-26 18:14; UTC

Uždarbis

Tech Executives Are Starting to Talk Tariffs. What It May Mean for Apple, Amazon Earnings -- Barrons.com

2025-04-26 15:00; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Trump 2.0 Era Brings Flurry of Crypto Deals -- WSJ

2025-04-26 08:20; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-04-25 21:24; UTC

Svarbiausios naujienos

Cargo Shipments From China to the U.S. Dwindle -- WSJ

2025-04-25 20:50; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-04-25 20:45; UTC

Svarbiausios naujienos

Stocks Claw Back Most of April's Tariff Losses -- WSJ

2025-04-25 20:39; UTC

Uždarbis

The Score: Tesla, Capital One, Boeing and More Stocks That Defined the Week -- WSJ

2025-04-25 20:37; UTC

Svarbiausios naujienos

Trump Administration Lays Out Tariff Roadmap to Streamline Trade Talks -- WSJ

2025-04-25 20:19; UTC

Svarbiausios naujienos

Nasdaq Climbs More Than 1% as Stocks Finish Strong Week -- WSJ

2025-04-25 20:15; UTC

Uždarbis

Week's Best: A Dividend Expert's Best Advice -- Barrons.com

2025-04-25 19:23; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Extend Weekly Losses -- Market Talk

2025-04-25 19:18; UTC

Rinkos pokalbiai

Oil Futures End Choppy Week With Losses -- Market Talk

2025-04-25 18:47; UTC

Rinkos pokalbiai

Gold Extends Pullback to Close Week -- Market Talk

2025-04-25 18:39; UTC

Svarbiausios naujienos

Nasdaq, Dow Industrials About Flat; Analysts Caution on Trump Tariffs -- WSJ

2025-04-25 18:34; UTC

Įsigijimai, susijungimai, perėmimai

Goldman Sachs Upgrades Schwab Stock. Here's Why. -- Barrons.com

2025-04-25 18:32; UTC

Rinkos pokalbiai
Uždarbis

Global Equities Roundup: Market Talk

2025-04-25 18:32; UTC

Rinkos pokalbiai
Uždarbis

Carriers See Tariffs Driving Up Phone Prices, Slowing Upgrades -- Market Talk

2025-04-25 18:08; UTC

Uždarbis

Sphere Entertainment Deal Is a Win for Shareholders as Banks Take a Hit -- Barrons.com

2025-04-25 17:55; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Rises By 2 to 483 -- Market Talk

2025-04-25 17:40; UTC

Svarbiausios naujienos

Consumers Continue to Sour on the Economy -- 4th Update

2025-04-25 17:38; UTC

Uždarbis

Centene Stock Falls on Medicaid Cost Worries -- Barrons.com

2025-04-25 17:07; UTC

Rinkos pokalbiai

Oil Futures Turn Higher in Quiet Trade -- Market Talk

2025-04-25 16:54; UTC

Rinkos pokalbiai
Uždarbis

Mobile Carriers See Stronger Activity on Bigger Price Tags, Tariffs -- Market Talk

2025-04-25 16:46; UTC

Uždarbis

Reddit, Meta, and Pinterest Stocks Rise. How Alphabet's Earnings Are Giving Them a Boost. -- Barrons.com

2025-04-25 16:20; UTC

Rinkos pokalbiai
Uždarbis

Basic Materials Roundup: Market Talk

2025-04-25 16:12; UTC

Svarbiausios naujienos

Dow Industrials Fall; China Plans Economic Support During Trade Battle -- WSJ

2025-04-25 16:03; UTC

Uždarbis

AbbVie Stock Rises Despite Risks as Earnings Beat Forecasts -- Barrons.com

2025-04-25 15:52; UTC

Rinkos pokalbiai

Grains Mixed on Low Volume Trade -- Market Talk

Akcijų palyginimas

Kainos pokytis

Aurinia Pharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

19.19% į viršų

12 mėnesių prognozė

Vidutinis 9.75 USD  19.19%

Aukščiausias 11 USD

Žemiausias 8 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Aurinia Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

4 ratings

4

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

7.73 / 8.32Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bullish Evidence

Vidutinės trukmės periodas

Strong Bullish Evidence

Ilgalaikis periodas

Bullish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.